Fellowship · Shreveport, LA
Sponsored by LSU Health Sciences Center
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 447 citations · Prakash Neupane
A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.
Nature medicine · 2025 · 86 citations · David Sommerhalder
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2026 · 26 citations · Srinivas Devarakonda
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 137 citations · Srinivas Devarakonda
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 174 citations · Srinivas Devarakonda
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 44 citations · Srinivas Devarakonda
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 191 citations · Prakash Neupane
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.
The New England journal of medicine · 2026 · 24 citations · David Sommerhalder